Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NMNAT1 pseudogene 4 (NMNAT1P4) is a pseudogene related to the NMNAT1 (Nicotinamide mononucleotide adenylyltransferase 1) gene, which encodes a key nuclear enzyme in NAD biosynthesis, essential for normal cell metabolism and associated with diseases such as Leber congenital amaurosis when mutated. However, as a pseudogene, NMNAT1P4 does not encode a functional protein and is not known to participate in biological pathways, disease mechanisms, or serve as a therapeutic target. Pseudogenes like NMNAT1P4 are considered non-functional genomic sequences that may arise from duplication events of protein-coding genes. GeneCards lists NMNAT1P4 among several recognized NMNAT1 pseudogenes on different chromosomes (including chromosome 4). There is no evidence that NMNAT1P4 has clinical, pharmacological, or biomarker utility. The closely related functional gene NMNAT1 (nicotinamide mononucleotide adenylyltransferase 1) is an enzyme involved in NAD biosynthesis and is a recognized therapeutic and research target. NMNAT1 pseudogene 4 is distinct from NMNAT1 and is not itself a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMNAT1 pseudogene 4 (NMNAT1P4).